ISOX INACT

Discontinued Product

5808 has been discontinued.

View all Bromodomains products.
说明: Negative control for PF-CBP1
化学名: 5-(Dimethyl-1,2-oxazol-4-yl)-2-[2-(4-methoxyphenyl)ethyl]--4,6-dimethyl-1-[2-(morpholin-4-yl)ethyl]-1H-1,3-benzodiazole
纯度: ≥98% (HPLC)
说明书
引用文献
评论
文献 (4)

生物活性 for ISOX INACT

ISOX INACT is a negative control for PF CBP1. Exhibits negligible activity at CBP and BRD4.

Active Analog also available.

许可信息

Sold for research purposes under agreement from Pfizer Inc.

技术数据 for ISOX INACT

分子量 488.62
公式 C29H36N4O3
储存 Store at +4°C
纯度 ≥98% (HPLC)
PubChem ID 121237856
InChI Key FTOHXUPHICJSCR-UHFFFAOYSA-N
Smiles CC(ON=C1C)=C1C2=C(C)C(N=C(CCC3=CC=C(OC)C=C3)N4CCN5CCOCC5)=C4C=C2C

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

参考文献 for ISOX INACT

参考文献是支持产品生物活性的出版物。

Chekler et al (2015) Transcriptional profiling of a selective CREB binding protein bromodomain inhibitor highlights therapeutic opportunities. Chem.Biol. 22 1588 PMID: 26670081

按标靶查看相关产品

按产品操作查看相关产品

查看全部 Bromodomain Controls

关键词: ISOX INACT, ISOX INACT supplier, ISOXINACT, negative, control, PFCBP1, bromodomains, CBP, BRD4, Bromodomains, 5808, Tocris Bioscience

篇 ISOX INACT 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 ISOX INACT 的引用文献。

ISOX INACT 的评论

目前没有该产品的评论。 Be the first to review ISOX INACT and earn rewards!

Have you used ISOX INACT?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Stem Cell Research Product Guide

Stem Cell Research Product Guide

This product guide provides a background to the use of small molecules in stem cell research and lists over 200 products for use in:

  • Self-renewal and Maintenance
  • Differentiation
  • Reprogramming
  • Organoid Generation
  • GMP and Ancillary Material Grade Products
Epigenetics Scientific Review

Epigenetics Scientific Review

Written by Susanne Müller-Knapp and Peter J. Brown, this review gives an overview of the development of chemical probes for epigenetic targets, as well as the impact of these tool compounds being made available to the scientific community. In addition, their biological effects are also discussed. Epigenetic compounds available from Tocris are listed.

Epigenetics in Cancer Poster

Epigenetics in Cancer Poster

This poster summarizes the main epigenetic targets in cancer. The dysregulation of epigenetic modifications has been shown to result in oncogenesis and cancer progression. Unlike genetic mutations, epigenetic alterations are considered to be reversible and thus make promising therapeutic targets.

Rheumatoid Arthritis Poster

Rheumatoid Arthritis Poster

Rheumatoid arthritis (RA) is a chronic destructive inflammatory autoimmune disease that results from a breakdown in immune tolerance, for reasons that are as yet unknown. This poster summarizes the pathology of RA and the inflammatory processes involved, as well as describing some of the epigenetic modifications associated with the disease and the potential for targeting these changes in the discovery of new treatments.